BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32412777)

  • 21. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop.
    Li H; Zhang H; Wang G; Chen Z; Pan Y
    Biomed Pharmacother; 2020 Sep; 129():109904. PubMed ID: 32559617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    Chen JB; Zhu YW; Guo X; Yu C; Liu PH; Li C; Hu J; Li HH; Liu LF; Chen MF; Chen HQ; Xiong-Bing Z
    J Cell Physiol; 2019 Aug; 234(8):13592-13601. PubMed ID: 30609030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
    Huo W; Tan D; Chen Q
    Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of
    Meng Q; Wang L; Lv Y; Wu J; Shi W
    Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
    [No Abstract]   [Full Text] [Related]  

  • 28. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 29. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 30. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
    Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA DDX11-AS1 promotes esophageal carcinoma cell proliferation and migration through regulating the miR-514b-3p/RBX1 axis.
    Wu C; Wang Z; Tian X; Wang J; Zhang Y; Wu B
    Bioengineered; 2021 Dec; 12(1):3772-3786. PubMed ID: 34281459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
    Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J
    J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
    Hu Y; Zhang Y; Ding M; Xu R
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
    Zhou B; Guo H; Tang J
    Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis.
    Zhang W; Zhang J; Hu Z; Sun W; Xu L; Chu H; Wang X; Fu Q
    Mol Biotechnol; 2022 Nov; 64(11):1259-1269. PubMed ID: 35556220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway.
    Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L
    Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
    Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.